122
Participants
Start Date
May 6, 2019
Primary Completion Date
November 2, 2020
Study Completion Date
November 30, 2020
Levonorgestrel (LNG)
LNG tablet(s) were administered by mouth in a directly observed manner.
University of the Witwatersrand Helen Joseph (WITS HJH) CRS (11101), Johannesburg
Family Clinical Research Unit (FAM-CUR) CRS (8950), Cape Town
Weill Cornell Upton CRS (7803), New York
31802 Thai Red Cross AIDS Research Centre (TRC-ARC) CRS, Bangkok
Pitt CRS (1001), Pittsburgh
Hosp. of the Univ. of Pennsylvania CRS (6201), Philadelphia
Kenya Medical Research Institute/Walter Reed Project Clinical Research Center (KEMRI/WRP) CRS (12501), Kericho
12101 Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS, Rio de Janeiro
Unc Aids Crs (3201), Chapel Hill
31784 Chiang Mai University HIV Treatment CRS, Chiang Mai
2701 Northwestern University CRS, Chicago
Rush Univ. Med. Ctr. ACTG CRS (2702), Chicago
Trinity Health and Wellness Center CRS (31443), Dallas
Gaborone CRS (12701), Gaborone
Blantyre CRS (30301), Blantyre
Malawi CRS (12001), Lilongwe
Soweto ACTG CRS (12301), Johannesburg
Durban Adult HIV CRS (11201), Durban
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
NETWORK